Cargando…
Application of the Meet-URO score to metastatic renal cell carcinoma patients treated with second- and third-line cabozantinib
BACKGROUND: The addition of neutrophil-to-lymphocyte ratio (NLR) and bone metastases to the International Metastatic RCC Database Consortium (IMDC) score (by the Meet-URO score) has been shown to better stratify pretreated metastatic renal cell carcinoma (mRCC) patients receiving nivolumab. This stu...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8883304/ https://www.ncbi.nlm.nih.gov/pubmed/35237353 http://dx.doi.org/10.1177/17588359221079580 |